Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Essential phospholipids for nonalcoholic fatty liver disease associated with metabolic syndrome: A systematic review and network meta-analysis
Asad Izziddin Dajani, Branko Popović
World Journal of Clinical Cases (2020) Vol. 8, Iss. 21, pp. 5235-5249
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Non-alcoholic fatty liver disease in adults: clinic, diagnostics, treatment. Guidelines for therapists, third version
Л. Б. Лазебник, Е. В. Голованова, С. В. Туркина, et al.
Experimental and Clinical Gastroenterology (2021) Vol. 1, Iss. 1, pp. 4-52
Open Access | Times Cited: 121
Nonalcoholic fatty liver disease: Current therapies and future perspectives in drug delivery
Inês Domingues, Isabelle Leclercq, Ana Beloqui
Journal of Controlled Release (2023) Vol. 363, pp. 415-434
Closed Access | Times Cited: 27
Guideline for the Prevention and Treatment of Metabolic Dysfunction-associated Fatty Liver Disease (Version 2024)
Jian‐Gao Fan, Xiaoyuan Xu, Rui-Xu Yang, et al.
Journal of Clinical and Translational Hepatology (2024) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 7
Regression of Liver Steatosis Following Phosphatidylcholine Administration: A Review of Molecular and Metabolic Pathways Involved
Darya Osipova, К. Д. Кокорева, Л. Б. Лазебник, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 30
Advances in Mass Spectrometry-Based Blood Metabolomics Profiling for Non-Cancer Diseases: A Comprehensive Review
Ekaterina Demicheva, Vladislav Dordiuk, Fernando Polanco Espino, et al.
Metabolites (2024) Vol. 14, Iss. 1, pp. 54-54
Open Access | Times Cited: 7
Predicting Non-Alcoholic Steatohepatitis: A Lipidomics-Driven Machine Learning Approach
Thomai Mouskeftara, Georgios Kalopitas, Theodoros Liapikos, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5965-5965
Open Access | Times Cited: 4
Clinical Guidelines of the Russian Society for the Study of the Liver, Russian Gastroenterological Association, Russian Society for the Prevention of Non-Communicable Diseases, Russian Association of Endocrinologists, Russian Scientific Medical Society of Therapists, National Society of Preventive Cardiology, Russian Association of Gerontologists and Geriatricians on Non-Alcoholic Fatty Liver Disease
В. Т. Ивашкин, О. М. Драпкина, M. V. Maevskaya, et al.
Russian Journal of Gastroenterology Hepatology Coloproctology (2025) Vol. 35, Iss. 1, pp. 94-152
Open Access
Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver disease
Inês Domingues, Hafsa Yagoubi, Wunan Zhang, et al.
Drug Delivery and Translational Research (2024) Vol. 14, Iss. 10, pp. 2917-2929
Open Access | Times Cited: 3
Agents for the treatment of fatty liver disease: focus on essential phospholipids
Asad Izziddin Dajani, A. Abu-Hammour
Drugs & Therapy Perspectives (2021) Vol. 37, Iss. 6, pp. 249-264
Open Access | Times Cited: 18
Soybean polyenylphosphatidylcholine (PPC) is beneficial in liver and extrahepatic tissue injury: An update in experimental research
Ki M. Mak, Aditya C. Shekhar
The Anatomical Record (2023) Vol. 307, Iss. 6, pp. 2162-2186
Closed Access | Times Cited: 7
Exploring the Protective Effects and Mechanism of Crocetin From Saffron Against NAFLD by Network Pharmacology and Experimental Validation
Zijin Xu, Susu Lin, Junjie Gong, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 16
Essential phospholipids decrease apoptosis and increase membrane transport in human hepatocyte cell lines
Dominik Wupperfeld, Gert Fricker, Béatrice Bois De Fer, et al.
Lipids in Health and Disease (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 11
Offspring NAFLD liver phospholipid profiles are differentially programmed by maternal high-fat diet and maternal one carbon supplement
Hui Peng, Jiangyuan Li, Huiting Xu, et al.
The Journal of Nutritional Biochemistry (2022) Vol. 111, pp. 109187-109187
Open Access | Times Cited: 10
Correlation of Objective Endpoints and Subjective Patient-Reported Outcomes in NAFLD Treatment with Essential Phospholipids: Real-World Data Based on Pooled Analysis of Observational Studies
В. Т. Ивашкин, M. V. Maevskaya, Е. Н. Широкова, et al.
Drugs - Real World Outcomes (2021) Vol. 8, Iss. 3, pp. 369-382
Open Access | Times Cited: 13
Healthcare practitioners’ diagnostic and treatment practice patterns of nonalcoholic fatty liver disease in Poland: a cross-sectional survey
Marek Hartleb, Agnieszka Mastalerz–Migas, Piotr Kowalski, et al.
European Journal of Gastroenterology & Hepatology (2021) Vol. 34, Iss. 4, pp. 426-434
Open Access | Times Cited: 12
Non-alcoholic fatty liver disease: a current challenge of interdisciplinary research
Elena V. Biryukova
Meditsinskiy sovet = Medical Council (2024), Iss. 6, pp. 72-80
Open Access | Times Cited: 1
Lipid composition of blood plasma and epithelium of the jejunal mucosa in calves with dyspepsia and its correction
V. Gryshchenko, Олена Данченко, С. А. Ткачук, et al.
Regulatory Mechanisms in Biosystems (2023) Vol. 14, Iss. 2, pp. 319-324
Open Access | Times Cited: 4
Combined hepatoprotective pharmacotherapy for liver disease
Sergey V. Okovityi, K. L. Raikhelson, V. A. Prikhodko
Experimental and Clinical Gastroenterology (2022), Iss. 7, pp. 5-20
Open Access | Times Cited: 4
Essential phospholipids impact cytokine secretion and alter lipid-metabolizing enzymes in human hepatocyte cell lines
Dominik Wupperfeld, Gert Fricker, Béatrice Bois De Fer, et al.
Pharmacological Reports (2024) Vol. 76, Iss. 3, pp. 572-584
Open Access
Aminotransferases activity on additional therapy in rheumatoid arthritis patients with liver disease.
I. Klymas, Л. В. Хіміон
Journal of Clinical Medicine of Kazakhstan (2024) Vol. 21, Iss. 2, pp. 89-94
Open Access
Silencing of Hepatic AATF Ameliorates Metabolic Dysfunction Associated Steatohepatitis by Promoting Fatty Acid β-Oxidation in Experimental models
Akshatha N. Srinivas, Diwakar Suresh, M. Moorthy, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Modern aspects of therapy of metabolic associated liver disease in patients with type 2 diabetes mellitus
С. В. Булгакова, Yu. A. Dolgikh, Л. А. Шаронова, et al.
Meditsinskiy sovet = Medical Council (2024), Iss. 16, pp. 184-192
Open Access
Comment on Clayton-Chubb et al. Understanding NAFLD: From Case Identification to Interventions, Outcomes, and Future Perspectives. Nutrients 2023, 15, 687
Ludovico Abenavoli, Giuseppe La Torre, Nataša Milić
Nutrients (2023) Vol. 15, Iss. 13, pp. 2907-2907
Open Access | Times Cited: 1
Nonalcoholic liver disease: review with a focus on risks of progression
Daria Teplyuk, M. Ch. Semenistaya, S. M. Sorokoletov, et al.
Experimental and Clinical Gastroenterology (2021), Iss. 8, pp. 167-174
Open Access | Times Cited: 1
Essential phospholipids in fatty liver diseases
Peter Minárik, Eva Koscova
Evidence for Self-Medication (2021) Vol. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top